# Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

> **NCT00004165** · PHASE3 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** melphalan
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00004165
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004165, "Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*